The latest analyst coverage could presage a bad day for Denali Therapeutics Inc. ( NASDAQ:DNLI ), with the analysts...
Denali Therapeutics ( NASDAQ:DNLI ) First Quarter 2024 Results Key Financial Results Net loss: US$101.8m (loss narrowed...
Denali (DNLI) Q1 loss narrows year over year due to lower expenses despite nil revenues.